Evidence map›Paper›PMID 42147982›Full record

ArticleInfection and drug resistance2026

Clinical Risk Factors and Outcomes of Carbapenem-Resistant P

Xiaoxiao Li, Tao Zhang, Tong Liu, Fenfen Xiang, Guotai Sun, Jing Tian, Mengzhe Zhang, Zhengrong Zhong

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoxiao Li *Laboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.
Tao Zhang *Laboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.ORCID 0000-0002-8649-5475
Tong LiuDepartment of Molecular Science, Uppsala Biocenter, Swedish University of Agricultural Science, Uppsala, 75007, Sweden.
Fenfen XiangLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.
Guotai SunLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.ORCID 0009-0001-1936-4141
Jing TianLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.
Mengzhe ZhangLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.
Zhengrong ZhongLaboratory Medicine Department, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200062, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The global spread of carbapenem-resistant Methods: A retrospective case-control study of patients with Results: The significant risk factors for CRPA infection were hypoproteinemia (OR=4.285, Conclusion: Our findings help identify patients at high risk for CRPA infection and underscore the importance of antimicrobial stewardship and infection control measures in hospital settings.

Indexed as

antimicrobial resistancecarbapenem-resistant Pseudomonas aeruginosanosocomial infectionrisk factors

Identifiers

PMID42147982
PMCPMC13179763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.